WallStreetZenWallStreetZen

AnalystsGraig Suvannavejh
Graig Suvannavejh's Stock Forecasts

Analyst Ranking
Bottom 7%
#4244 out of 4529 analysts
Average Return
-3.12%
Win Rate
49%44 out of 89
Risk vs Reward
Poor
Good

Graig Suvannavejh's 5 best and worst ratings

Name / TickerGain/LossEntry PriceExit PricePeriodRating
Eyepoint Pharmaceuticals IncEYPT
+183.54%$7.29$20.67
2023-11-01 -
2024-03-28
Strong Buy
Halozyme Therapeutics IncHALO
+136.15%$18.45$43.57
2020-01-07 -
2021-01-08
Strong Buy
Cerevel Therapeutics Holdings IncCERE
+97.37%$16.71$32.98
2020-12-09 -
2021-12-09
Strong Buy
Vor Biopharma IncVOR
+79.24%$42.59$8.84
2021-03-01 -
2022-03-01
Strong Sell
Karuna Therapeutics IncKRTX
+77.92%$185.38$329.83
2023-08-03 -
2024-03-15
Strong Buy

Graig Suvannavejh Analyst Color

Get additional color on Graig Suvannavejh's coverage of popular stocks

Graig Suvannavejh's Stock Coverage

Name / TickerNo. RatingsRatingPrice TargetUpside/DownsideActionDate
Axsome Therapeutics IncAXSM
14Strong Buy$109.00+36.59%Maintains
19 hours ago
Corvus Pharmaceuticals IncCRVS
1Hold$3.50+96.63%Maintains
2 days ago
Apellis Pharmaceuticals IncAPLS
3Hold$60.00+2.08%Maintains
2 days ago
Amylyx Pharmaceuticals IncAMLX
4Strong Buy$32.00+1,026.76%Reiterates
21 days ago
Immunocore Holdings PLCIMCR
5Strong Buy$90.00+38.46%Maintains
24 days ago
Harmony Biosciences Holdings IncHRMY
14Strong Buy$40.00+19.12%Maintains
a month ago
Intra Cellular Therapies IncITCI
7Strong Buy$82.00+18.50%Maintains
a month ago
Eyepoint Pharmaceuticals IncEYPT
3Strong Buy$39.00+88.68%Maintains
a month ago
Cerevel Therapeutics Holdings IncCERE
9Hold$45.00+6.46%Maintains
a month ago
Adverum Biotechnologies IncADVM
3Strong Buy$40.00+182.89%Maintains
2 months ago
Halozyme Therapeutics IncHALO
3Hold$40.00-1.67%Maintains
2 months ago
Terns Pharmaceuticals IncTERN
5Strong Buy$10.00+52.44%Maintains
4 months ago
Alector IncALEC
4Strong Buy$9.00+49.50%Maintains
4 months ago
Bioxcel Therapeutics IncBTAI
8Hold$4.00+41.84%Reiterates
7 months ago
Karuna Therapeutics IncKRTX
3Strong Buy$258.00-21.78%Maintains
8 months ago
Rain Oncology IncRAIN
5Hold$1.00-17.36%Downgrades
10 months ago
Athira Pharma IncATHA
2Strong Buy$5.00+82.48%Maintains
10 months ago
Immatics NvIMTX
2Strong Buy$12.00+14.18%Initiates Coverage On
a year ago
Vigil Neuroscience IncVIGL
1Strong Buy$15.00+339.88%Initiates Coverage On
a year ago
Insmed IncINSM
1Strong Buy$28.00N/AInitiates Coverage On
a year ago
Rhythm Pharmaceuticals IncRYTM
3Strong Buy$35.00N/AMaintains
a year ago
Kodiak Sciences IncKOD
4Hold$8.00N/AMaintains
a year ago
Tg Therapeutics IncTGTX
2Strong Sell$26.00N/ADowngrades
2 years ago
Disc Medicine IncIRON
2Strong Buy$18.00N/AMaintains
2 years ago
Valneva SeVALN
1Strong Buy$34.00N/AInitiates Coverage On
3 years ago
Design Therapeutics IncDSGN
1Hold$28.00N/AInitiates Coverage On
3 years ago
Edgewise Therapeutics IncEWTX
1Hold$31.00N/AInitiates Coverage On
3 years ago
Vor Biopharma IncVOR
1Strong Sell$19.00N/AInitiates Coverage On
3 years ago
Innate Pharma SaIPHA
1Hold$4.75N/AInitiates Coverage On
3 years ago
Codiak Biosciences IncCDAKQ
1Strong Buy$29.00N/AInitiates Coverage On
3 years ago
Arcutis Biotherapeutics IncARQT
2Strong Buy$36.00N/AUpgrades
3 years ago
Cytokinetics IncCYTK
1Hold$16.00N/AInitiates Coverage On
3 years ago
Galapagos NvGLPG
1Strong SellN/AN/ADowngrades
3 years ago
Prelude Therapeutics IncPRLD
1Hold$37.00N/AInitiates Coverage On
3 years ago
Jazz Pharmaceuticals PLCJAZZ
1Strong Sell$128.00N/ADowngrades
4 years ago
Tricida IncTCDAQ
1Hold$10.00N/ADowngrades
4 years ago
Flexion Therapeutics IncFLXN
1Hold$15.00N/AInitiates Coverage On
4 years ago
Momenta Pharmaceuticals IncMNTA
1Hold$29.00N/AInitiates Coverage On
4 years ago
Horizon Therapeutics Public Ltd CoHZNP
1Hold$35.00N/AInitiates Coverage On
4 years ago
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.